Zheng Yi, Xu Shangyan, Kang Huili, Zhan Weiwei
Department of Ultrasound, Rui Jin Hospital, School of Medicine, Shanghai JiaoTong University.
Department of Ultrasound, Shanghai PuNan Hospital, Shanghai, China.
Ultrasound Q. 2018 Jun;34(2):77-83. doi: 10.1097/RUQ.0000000000000350.
This study aimed to evaluate a new risk stratification system, the American College of Radiology (ACR) Thyroid Imaging Reporting and Data System (TI-RADS), published in 2017.
From January 2015 to December 2016, 1033 thyroid nodules in 1013 patients who had undergone sonography and thyroid surgery or fine-needle aspiration (FNA) in our hospital were included. The sonographic features were described in a standard manner and analyzed according to the white paper of the ACR TI-RADS Committee. Nodules were assigned points for each feature, and the points were totaled to determine the final TI-RADS levels.
Of the 1033 nodules, 725 were benign and 308 were malignant proven by operation or FNA. The malignant risk was associated with the composition, echogenicity, shape, margins, and echogenic foci of the nodules (P < 0.001). The calculated risk of malignancy was higher in nodules with macrocalcifications than those with peripheral calcifications, which is different from the ACR TI-RADS. The calculated malignancy rates of nodules with TR5, TR4, TR3, and TR2 were 67.1%, 13.0%, 1.1%, and 0%, respectively, which showed a higher malignant risk than the suggested threshold of TR5 in the ACR TI-RADS. Six nodules with TR4 recommended for no follow-up and 55 nodules with TR5 recommended for follow-up were malignant with cervical lymph node metastasis.
The ACR TI-RADS provides effective malignancy risk stratification for thyroid nodules and was useful for the decision for FNA. However, the points assigned for echogenic foci, the set of the TI-RADS risk thresholds, and FNA thresholds may need more consideration and prospective validation.
本研究旨在评估2017年发布的一种新的风险分层系统——美国放射学会(ACR)甲状腺影像报告和数据系统(TI-RADS)。
纳入2015年1月至2016年12月期间在我院接受超声检查及甲状腺手术或细针穿刺活检(FNA)的1013例患者的1033个甲状腺结节。按照标准方式描述超声特征,并根据ACR TI-RADS委员会的白皮书进行分析。为每个特征的结节分配分数,并将分数相加以确定最终的TI-RADS级别。
1033个结节中,经手术或FNA证实725个为良性,308个为恶性。恶性风险与结节的成分、回声、形状、边界及内部回声灶有关(P<0.001)。粗大钙化结节的计算恶性风险高于周边钙化结节,这与ACR TI-RADS不同。TI-RADS 5类(TR5)、4类(TR4)、3类(TR3)和2类(TR2)结节的计算恶性率分别为67.1%、13.0%、1.1%和0%,显示出比ACR TI-RADS中TR5类建议阈值更高的恶性风险。6个建议不随访的TR4类结节及55个建议随访的TR5类结节为恶性且伴有颈部淋巴结转移。
ACR TI-RADS为甲状腺结节提供了有效的恶性风险分层,对FNA决策有用。然而,内部回声灶的赋分、TI-RADS风险阈值的设定及FNA阈值可能需要更多的考虑和前瞻性验证。